The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Surgical Trial to Evaluate the Impact of a Lymphoscintigraphy Prior to Sentinel Node Biopsy in Early Breast Cancer
Official Title: Randomized Controlled Multicenter Surgical Trial to Evaluate the Impact of a Lymphoscintigraphy Prior to Sentinel Node Biopsy in Early Breast Cancer; SenSzi (GBG80)
Study ID: NCT02481128
Brief Summary: Sentinel node biopsy is a well established tool for axillary staging in early breast cancer. So far the impact of a preoperative lymph node scintigraphy is unclear. This study aims to clarify whether a preoperative lymphoscintigraphy is of additional benefit in a prospective randomized multicenter study design.
Detailed Description: Sentinel node biopsy is a well established tool for axillary staging in early breast cancer. So far the impact of a preoperative lymph node scintigraphy is unclear. Several studies indicate sentinel node biopsy to be a reliable method irrespective of prior lymph node scintigraphy, but data from prospective randomized trials are not available. Although a preoperative lymph node scintigraphy is not explicitly demanded in current S3 guidelines in Germany its performance is a common practice. If a preoperative lymphoscintigraphy could be safely omitted, possible benefits are a facilitation of the preoperative workflow as well as cost reduction for health care systems. This study aims to clarify whether a preoperative lymphoscintigraphy is of additional benefit in a prospective randomized study design. In the two study arms sentinel node biopsy is performed either with or without knowledge of the preoperative lymphoscintigraphy findings. Primary end point is the average number of histologically detected sentinel lymph nodes per patient in both treatment arms.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Kliniken Essen-Mitte, Essen, Nordrhein-Westfalen, Germany
Brustzentrum im Klinikum Ansbach, Ansbach, , Germany
Brustzentrum am Hochwaldkrankenhaus Bad Nauheim, Bad Nauheim, , Germany
Kreisklinik Ebersberg, Brustzentrum, Ebersberg, , Germany
Klinik für Frauenheilkunde & Geburtshilfe, Klinikum Esslingen, Esslingen, , Germany
Agaplesion Markus Krankenhaus Frankfurt, Brustzentrum, Frankfurt a. M., , Germany
Franziskus Hospital Harderberg, Brustzentrum Osnabrück, Georgsmarienhütte, , Germany
Asklepios Harzkliniken Goslar, Brustzentrum, Goslar, , Germany
Klinikum Gütersloh, Klinik für Frauenheilkunde und Geburtshilfe, Gütersloh, , Germany
Sankt Elisabeth Krankenhaus Gütersloh, Frauenklinik, Gütersloh, , Germany
Universitätsklinikum Hamburg Eppendorf, Hamburg, , Germany
Kreiskrankenhaus Bergstrasse, Brustzentrum, Heppenheim, , Germany
Universitätsklinikum Schleswig-Holstein, Brustzentrum Kiel, Kiel, , Germany
Universitätsfrauenklinik Magdeburg, Brustzentrum, Magdeburg, , Germany
Evangelisches Krankenhaus Bethesda, Brustzentrum Niederrhein, Mönchengladbach, , Germany
Universitätsfrauenklinik am Klinikum Südstadt Rostock, Rostock, , Germany
DRK Krankenhaus Saarlouis, Brustzentrum, Saarlouis, , Germany
Leopoldina Krankenhaus Schweinfurt, Brustzentrum, Schweinfurt, , Germany
Klinikum St. Elisabeth Straubing, Brustzentrum, Straubing, , Germany
Katharinen Hospital Unna, Brustzentrum, Unna, , Germany
Kliniken Nordoberpfalz, Frauenklinik, Weiden, , Germany
Marien-Hospital Wesel, Brustzentrum, Wesel, , Germany
Brustzentrum Bern, Engerriedspital/Lindenhofspital, Bern, , Switzerland
Name: Sherko Kümmel, MD
Affiliation: Kliniken Essen-Mitte
Role: PRINCIPAL_INVESTIGATOR
Name: Thorsten Kühn, MD
Affiliation: Klinikum Esslingen
Role: STUDY_CHAIR
Name: Johannes Holtschmidt, MD
Affiliation: Kliniken Essen-Mitte
Role: STUDY_CHAIR